Humulin 50-50
Nearly Every State Seeing Large Surge in Diabetes »
"Nov. 15, 2012 -- The number of people diagnosed with diabetes in the U.S. jumped by 50% or more in 42 states and by more than 100% in 18 of those states in just under two decades, according to the latest snapshot from the CDC.
Read the Nearly Every State Seeing Large Surge in Diabetes article »
Humulin 50-50
HUMULIN® 50/50 (50-50 human insulin isophane suspension and human insulin injection)
(50% human insulin isophane suspension and 50% human insulin injection 10 mL vial(1000 units per vial)
(rDNA ORIGIN)
100 UNITS PER ML (U-100)
DRUG DESCRIPTION
Humulin is synthesized in a special non-disease-producing laboratory strain of Escherichia coli bacteria that has been genetically altered to produce human insulin. Humulin 50/50 is a mixture of 50% Human Insulin Isophane Suspension and 50% Human Insulin Injection (rDNA origin). It is an intermediate-acting insulin combined with the more rapid onset of action of Regular human insulin. The duration of activity may last up to 24 hours following injection. The time course of action of any insulin may vary considerably in different individuals or at different times in the same individual. As with all insulin preparations, the duration of action of Humulin 50/50 is dependent on dose, site of injection, blood supply, temperature, and physical activity. Humulin 50/50 is a sterile suspension and is for subcutaneous injection only. It should not be used intravenously or intramuscularly. The concentration of Humulin 50/50 is 100 units/mL (U-100).
Last reviewed on RxList: 9/13/2007
This monograph has been modified to include the generic and brand name in many instances.
Additional Humulin 50-50 Information
Humulin 50-50 - User Reviews
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Diabetes
Find tips and advances in treatment.






